Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Genprex Inc (GNPX)
NASDAQ:GNPX
Genprex (GNPX) Stock Price & Analysis
487 Followers
GNPX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.19 - $1.94
Previous Close$0.23
Volume309.72K
Average Volume (3M)293.22K
Market Cap
$13.67M
Enterprise Value$1.96M
Total Cash (Recent Filing)$11.71M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-0.4
Beta2.09
Next Earnings
Aug 13, 2019EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.61
Shares Outstanding59,434,822
10 Day Avg. Volume230,879
30 Day Avg. Volume293,218
Standard Deviation0.66
R-Squared0.00006
Alpha0.05
Financial Highlights & Ratios
Price to Book (P/B)1.18
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit0.08
Enterprise Value/Ebitda-0.38
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Genprex News
Ownership Overview
0.00% Insiders
3.80% Mutual Funds
8.53% Other Institutional Investors
87.67% Public Companies and
Individual Investors
GNPX FAQ
What was Genprex Inc’s price range in the past 12 months?
Genprex Inc lowest stock price was $0.19 and its highest was $1.94 in the past 12 months.
What is Genprex Inc’s market cap?
Currently, no data Available
When is Genprex Inc’s upcoming earnings report date?
Genprex Inc’s upcoming earnings report date is Aug 13, 2019 which is 1580 days ago.
How were Genprex Inc’s earnings last quarter?
Genprex Inc released its earnings results on May 15, 2019. The company reported -$0.141 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.141.
Is Genprex Inc overvalued?
According to Wall Street analysts Genprex Inc’s price is currently Overvalued.
Does Genprex Inc pay dividends?
Genprex Inc does not currently pay dividends.
What is Genprex Inc’s EPS estimate?
Genprex Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Genprex Inc have?
Genprex Inc has 59,434,822 shares outstanding.
What happened to Genprex Inc’s price movement after its last earnings report?
Genprex Inc reported an EPS of -$0.141 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Genprex Inc?
Currently, no hedge funds are holding shares in GNPX
---
Genprex Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
GNPX Sentiment 100%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Very Negative
Last 7 Days ▲ 2.3%
Last 30 Days ▼ 4.7%
Last 30 Days ▼ 4.7%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-81.21%
12-Months-Change
Fundamentals
Return on Equity
-159.31%
Trailing 12-Months
Asset Growth
-44.42%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Genprex Inc
Genprex, Inc. is a clinical stage gene therapy company, which engages in the development of novel proprietary technology platform for the treatment of cancer. It develops the Oncoprex immunogene therapy which targets the non-small cell lung cancer and other solid tumors. The company was founded by J. Rodney Varner in April 2009 and is headquartered in Austin, TX.
---
Top 5 ETFs holding GNPX
Vanguard Total Stock Market ETF
$249.22K
Up to five ETFs with an Outperform Smart Score that hold GNPX. The ETFs are listed according to market value of GNPX within the ETF
---